,GSM,Input
0,GSM2995080,"NS5 Mock ChIP, Rep1 protein expressed: NS5; treatment: mock Leo1 ChIP for NS5 mock treatment = "
1,GSM2750400,205Z_MSCB-167 cell type: neuronal progenitors; patient type: WB_2 fresh cells; Cell_1461; IPSC_Expression.xlsx = 
2,GSM2874918,TBS013-15_S15_L001 tissue source: PBMCs from Mtb exposed patients; cell type: Activated CD8+ T cells; cell subtype: Conventional processed data file:; count_matrix.txt; normalized_count_matrix.txt = 
3,GSM1966258,"single H9 hESCs differentiated for 72 hours [H9.72h_049] passage: passage 30-35; facs sorting: not sorted H9 cells were differentiated in E8 with BMP4 (5ng/ml), Activin A (25ng/ml) and CHIR99021 (1uM) for the first 2 days, then withdraw CHIR99021 for 2 days. Cells are sampled at the indicated time.; sc_time_course_ec.csv; H9.72h_049 = "
4,GSM3175287,C4_bruseq_fib cell type: Fibroblasts; subtype: Control; bru labeling time: 0.5 hours; assay: bruseq; time between bru labeling and rna extraction: 0 hours; labeling agent: Bromouridine (Bru) bru-labeled RNA = 
5,GSM3330901,RF-3N1-2 cell line: 3N1; alt status: ALT- 3N1; ribo-depleted RNA = 
6,GSM1396221,Single cell mRNA-seq_CSC8_E07 cell line: CSC8; cell type: Gliomasphere Cell Line processed data file: GBM_data_matrix.txt = 
7,GSM2877927,Antral_follicle_C1M1G tissue: Ovary; developmental stage: Antral C1M1G = 
8,GSM2424636,Normal_33 tissue: Normal T lymphocytes; diagnosis: Healthy; vital status: --; overall survival: --; gender: unknown; age: --; cytogenetic risk: --; peripheral blasts: --; bone marrow blasts: --; wbc: --; platelets: --; dnmt3a mutation: --; idh mutation: --; flt3-itd: --; npm1 mutation: -- Tajs = 
9,GSM3153193,scTrioSeq2Met_CRC10_LN1_023 disease: Carcinoma single cell DNA methylome seq = 
10,GSM1296808,WI-38 Clone #2 rep3 cell line: WI-38; cell type: hTERT-immortalized WI-38 primary human lung fibroblasts. Passage 23-27; cell divisions: 18; passage: 25 = 
11,GSM2711699,NC_Sox10GFP_1 cell type: SOX10+ neural crest S1; Neural Crest #1 = 
12,GSM3448501,34D00CSF condition: Subarachnoid Hemorrhage; anatomical location: Entire brain; rna source: total cell-free biofluid RNA; rna isolation kit: MiRVana Paris (Ambion) = 
13,GSM2307015,25-G12.CC019 diagnosis: Control; patientid: CC019 = 
14,GSM2158842,Pancreatic islet cell sample 943 tissue: Pancreatic islets; donor id: T2D 6; condition: T2D; age: 51; ethnicity: H; gender: M; cell subtype: beta = 
15,GSM2486812,HUVEC TCC hypoxia replicate 2 cell type: human umbilical vein endothelial cells (HUVEC) tethered conformation capture (TCC) = 
16,GSM2536550,5284_BA9_neg (bisulfite-Seq) cell type: NeuN neg; tissue: prefrontal cortex (BA9); individual id: 5284 = 
17,GSM2800827,DMSO/WCL treatment: DMSO control; antibody: whole cell lysate (wcl: input control) = 
18,GSM3161672,donor309pl7cell183 donor: donor309; donor age: 21.2 years; gender: female; tissue: bone marrow single-cell RNA; 1 out of 192 cells per donor = 
19,GSM2749850,202Z_MSCB-186 cell type: neuronal progenitors; patient type: WB_1 fresh cells; Cell_911; IPSC_Expression.xlsx = 
20,GSM2878307,MCF7-shCTRL Rep2 cell line background: MCF7; genotype/variation: shCTRL; cell type: ESA+CD24lowCD44+ cells UT_CTRL; ctrl3_S73 = 
21,GSM1813877,MGH53-P7-E11 cell type: oligodendroglioma single cell = 
22,GSM2878781,666_INPUT barcodes: Rel19; antibody: SUPT6H; antibody catalog#: A300-801A; antibody lot#: 1; cell line: K562 = 
23,GSM2074112,CY88CD45POS_2_B05_S401_comb disease state: melanoma; tumor index: 88 = 
24,GSM2448477,normal.ct-964 cell type: blood serum; group: healthy control cell-free DNA = 
25,GSM3663957,MC-102_RNA-Seq [FGC1247_s_6_1_ATTCAGAA-CAGGACGT] cohort: Penn Cohort 2; tissue: liver; individual: MC-102 = 
26,GSM1678805,3'READs Dicerkd nuc_rep2.1 cell line/type: HEK293 cells; subcellular fraction: nuclear; dicer knockdown: Yes 2_5dN1; Fastq of 2_5dN1 and 2_5dN2 merged = 
27,GSM1395400,Single cell mRNA-seq_MGH26_A02 patient id: MGH26; cell type: Glioblastoma; subtype: Pro processed data file: GBM_data_matrix.txt = 
28,GSM2373997,HE24W_EVT3_sc17 cell type: Extravillous trophoblast; cell population: HLA-G+; Stage: Week 24 mRNA with polyA tail = 
29,GSM1153238,"FAM11-01 Human peiripheral blood gender: Male In addition to HiSeq 2000, these Samples had to be furthered sequenced with (Hiseq2000 and GAIIx) to obtain enough reads = "
30,GSM1812828,MGH36-P7-G09 cell type: oligodendroglioma single cell = 
31,GSM2604776,PTR18-0322 patient: P0322; majorcluster: CD4_Cluster2-IL2RA; sampletype: PTR = 
32,GSM2880170,Primary T cell 143 cell type: Memory T cell; gender: male; disease status: healthy singles-C3-51; Transcript-indexed single-cell ATAC-seq; Open chromatin = 
33,GSM2232920,Control RNASeq 3 cell type: neuroblastoma cell line; cell line: SK-N-BE2; treatment: control = 
34,GSM2989752,colon_1059_LibRep_A_SeqRep_B Sex: F; self-identified ancestry: AA; age: 71; finding: no_finding; patient id: colon_1059; library id: colon_1059_A; library replicate: A; sequencing replicate: B; library bath id: ccmp2_lib_prep_plate_48_5 = 
35,GSM2372596,ChiP2_Input.fastq antibody: IgG; antibody vendor/catalog#: Signma = 
36,GSM1562847,G2_Exp1.069 cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted = 
37,GSM2858421,"K562_WT_H3K18Ac_ChIP_rep1 cell line: K562; genotype: wild type; chip antibody: H3K18Ac (Abcam, ab1191, Lot GR277130-1) = "
38,GSM3039305,RNASeq_hESC_WT_D0_R4 cell line: HUES64; cell type: human embryonic stem cells; genotype/variation: WT; stage/time point: D0 processed data file: genes_fpkm.txt = 
39,GSM2246326,GBM cell 2862 diagnosis: glioblastoma; plate id: 1001000247; well: E9; tissue: Tumor; patient id: BT_S4; tsne cluster: 8; cell type: Immune cell; neoplastic: Regular; selection: Neurons(Thy1) Single cell from Tumor; 1001000247.E9 = 
40,GSM2270841,1772122263_B11 tissue: stem cells; Sex: ?; age: 12d; inferred cell type: eProg1a ESMoleculeCounts.cef = 
41,GSM3170543,C19_04_S214 [colonies_scRNA-seq] donor id: donor 2; cell type: primary hematopoietic cells = 
42,GSM3342895,11162017-G02-NA19206 experiment: 11162017; well: G02; individual: NA19206; batch: b4 eset.rds; scqtl-counts.txt.gz; scqtl-annotation.txt; scqtl-annotation-description.txt; quality-single-cells.txt; genes-pass-filter.txt = 
43,GSM1424422,C42B_control_3 tissue: prostate; cell line: prostate cancer cell line C42B; treatment: control Sample 3 = 
44,GSM2702212,Ex.2 hiPS TNFSF8 locus cell type: induced pluripotent stem cells; bait: TNFSF8 = 
45,GSM1852912,Cy67-CD45pos-S2-G12_S84 tumor-of-origin: Cy67; classification (based on inferred cnvs): non-malignant (1); cell types for non-malignant cells: B-cells (2) single cell RNA-seq = 
46,GSM3170175,C13_05_S107 [colonies_scRNA-seq] donor id: donor 1; cell type: primary hematopoietic cells = 
47,GSM2718911,ID_128 tissue: breast tumor; intrinsic subtype: Luminal B 128LB_TAATGCGC-TATAGCCT = 
48,GSM2174669,CML2_CMLSC3 subject status: Chronic Myelogenous Leukemia (CML) patient; subject id: CML2; leukemia stage: Chronic Phase (Newly diagnosed); bcr-abl status: PRESENCE; tissue: bone marrow; cell type: CML stem cells (CMLSCs) CML2_S3 = 
49,GSM2236851,BPDCN Patient 27 cell type: plasmacytoid dendritic cells (pDCs); disease state: blastic plasmacytoid dendritic cell neoplasm (BPDCN); individual: Patient 27 Processed data in Series supplementary file RNA-Seq_FFPE_BPDCN_Normalized.xls = 
50,GSM2697633,scTrioSeq2Met_CRC01_MP1_249 disease state: Carcinoma single cell DNA methylome seq = 
51,GSM2826328,HSPC_JMML2_PL1_5C cell line: HSPC; method: mRNA targeting JMML2_PL1_5C = 
52,GSM1088207,M8_rTreg status: healthy; barcode: GTGCATCCTA = 
53,GSM3225875,GM12878 cell number 2059 cell type: GM12878 cell line GBC_265-49-Ad1-17-Ad2-4_S4; GBC_counts_GM12878_experiment2.txt = 
54,GSM1041199,"Tr.rna cell line: BJ cells; condition: Transformed cells (induced by RASG12V in the background of stable p53 and p16INK4A kds); protocol: BJ cells expressing hTERT, p16INK4A-KD, p53-KD and SV40 small T were retrovirally transduced with pBabe-puro-RASG12V = "
55,GSM2667769,neu14_mono_rep1 cell type: Neural cultures (14 days); fraction: Monosome (80S); molecule: Monosomal RNA rRNA-depleted; processed data file: tripseq_gene_tpms.tsv; processed data file: tripseq_transcript_tpms.tsv; Read 1 adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC; Read 2 adapter: AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT = 
56,GSM2048566,CSLKO2-32 data subset: Single Cell; genotype/variation: CSL -/-; tumor status: CSL KO Xenograft Tumor 2nd; treatment (notch activation or inhibition): n/a smart seq 2 single cell RNA; Processed data file: single_cell_all_rpkm.txt = 
57,GSM2180918,RHL1109 sample type: Cell line; cell line: H1437; batch: 1 processed data file : cell_line_FPKM.csv = 
58,GSM3004668,GM19130_PRO-cap cell type: lymphoblastoid cell line; population: YRI; individual: GM19130 Capped nascent RNA = 
59,GSM3536063,L025P tissue: non-tumor; tumor stage: early stage HCC.RNA-seq.35.samples.fpkm.txt; 314P = 
60,GSM3170735,C33_04_S118 [colonies_scRNA-seq] donor id: donor 2; cell type: primary hematopoietic cells = 
61,GSM1815352,MGH54-P8-H04 cell type: oligodendroglioma single cell = 
62,GSM2378063,MGH42_P15_G09 tumor: MGH42 = 
63,GSM1530482,VSD-05 VSD tissue: heart; disease state: ventricular septal defect VSD = 
64,GSM1261894,4inv patient id: 4; tissue source: laser micro-dissected archival FFPE tissue specimens; tissue type: invasive lung carcinoma (inv) = 
65,GSM2246176,GBM cell 2712 diagnosis: glioblastoma; plate id: 1001000245; well: C10; tissue: Tumor; patient id: BT_S4; tsne cluster: 11; cell type: Neoplastic; neoplastic: Neoplastic; selection: Neurons(Thy1) Single cell from Tumor; 1001000245.C10 = 
66,GSM3664641,Sample_T13-7 tissue: Whole blood; disease state: Control; treatment: Cardiopulmonary exercise; timepoint (day): 7; individual identifier: T13 processed data file: FES_isoforms_FPKM.txt = 
67,GSM3214985,lib2_AR_lib2_AR_T28_228_2_C6.S221 tissue: tumor (PDX MEL006); age: 28d on treatment; genotype: BRAFmut (V600E) SMARTseq2 (Picelli et a. 2014) = 
68,GSM2914591,WT_2.cDNA.003.C17 disease: wild-type control; cell type: Fibroblast; passage number: P4; c1 chip size: Large = 
69,GSM3528019,G4B_Control_3b Stage: 55 days; tissue: Control organoid 3; scrna-seq protocol: SmartSeq2 dissected cerebral organoid; Data_Fat4_Dchs1_805cells.csv = 
70,GSM2572635,MYC primer R1 biological rep1 technical rep 2 in HCT116 cell line cell line: HCT116; primer_us: GCCTCTCGCTGGAATTACTAC; primer_ds: CCCCGAAAACCGGCTTTTATAC = 
71,GSM2727337,MGH66-P07-C03 sample type: human tumor = 
72,GSM2824708,BJ_MYO_R1_T72_D02_scRNA-seq cell type: Foreskin Human Fibroblasts; cell line: hFib-MYOD line; mapped.fragments: 1509675; cells.in.well: 2; debris: FALSE; clump: FALSE; unusual.shape: FALSE; control: FALSE; media: DM; replicate: R1; time: T72 = 
73,GSM3016930,BM2_1 [RHC6939] tissue type/id#: Bone marrow sample 2; cell type: Bone marrow mesenchymal stem cell (hBMMSC) RHC6939_HS004-PE-R00162_L006 = 
74,GSM3663601,MC-54_RNA-Seq [FGC1248_s_3_1_GAGATTCC-GGCTCTGA] cohort: Penn Cohort 2; tissue: liver; individual: MC-54 = 
75,GSM2193316,PEER_DMSO_48h_rep3 type: T-ALL; gender: female; treatment: DMSO RNA-sequencing of PEER cells treated with DMSO for 48h = 
76,GSM1308777,T273_HpaII cell type: Hepatocellular carcinoma HpaII library (indicating unmodified cytosines) of the sample = 
77,GSM3176082,WTCHG_312341_701517 age: 57; gender: female; tissue: bone marrow; cell type: Erythroid precursors(ERP); replicate: technical replicate 1 donor_age57.0_female_ERP; sample extracted from cell population from given donor; countTable_ERP.txt = 
78,GSM1957377,whOrg5_H4_hOrg65d Stage: 65 days; tissue: Dissociated whole cerebral organoid Single cell H4 from human cerebral organoid experiment at 65d; whOrg5_H4_hOrg65d = 
79,GSM2749835,202Z_MSCB-171 cell type: neuronal progenitors; patient type: WB_1 fresh cells; Cell_896; IPSC_Expression.xlsx = 
80,GSM2557300,Pool_1427_AD006_indexed tissue: frontal cortex; Sex: Male; age: 25 yr = 
81,GSM2289192,I1_plate17_H_9 fsc-a: 120996; fsc-h: 118049; ssc-a: 48232; ssc-h: 47861; cd45ra: 417; cd135: 2179; cd90: 2372; cd49f: 379; lin: 456; cd34: 3079; cd38: 159; cd10: 142; facs time: 27292 = 
82,GSM3739549,Human fetal liver (G7_103#1215) sample type: Freshly isolated human fetal liver homegenate; sample id: Human fetal liver 2; Sex: Unknown; age: 16 postconceptional weeks (pcw); developmental stage: fetal = 
83,GSM450053,YanHuang1_methy_rep38 cell type: human peripheral blood mononuclear cells sample for paired-end library with insert size of 128 bp = 
84,GSM2298984,242-58-33426499 cell type: Fibroblasts; age: 58 FINAL_master_list_of_genes_counts_MIN.Fibroblasts_PORT.txt = 
85,GSM2394623,Colorectal tissue Adenoma 46 pathology: Adenoma small RNA = 
86,GSM3225128,GM12878 cell number 1312 cell type: GM12878 cell line GBC_139-68-Ad1-44-Ad2-89_S665; GBC_counts_GM12878_experiment2.txt = 
87,GSM3734165,CFTRneg_Treated_4 tissue: Colonic adenocarcinoma-derived cell line; genotype: CFTR null; clone: N6; treatment: 100ng/ml TNFa for 2 hours Generated using CRISPR/Cas9-mediated mutagenesis of CFTR = 
88,GSM3466787,healthy_1 cell type: Peripheral blood mononuclear cells (PBMCs); disease: healthy 150bp paired-end sequencing = 
89,GSM3310392,huc2_p5_sti_11 [T5_16] donor id: Donor2; cell type: umbilical cord derived mesenchymal stem cell (MSC); passage: 5; treatment: IFNγ+TNFα T5_16 = 
90,GSM2188700,BRx-172_2_111114 donor: BRx-172; ptprc: low; erbb2: low; er: negative; pr: negative; her2: negative = 
91,GSM1816454,"THP1_115_IgG cell line: THP-1; cell type: MLL-AF9 leukemia; chip antibody: Rabbit IgG, purified (Millipore, PP64B, lot DAM1852692, 1mg/ml) Used in final analysis: no; ChIP conditions: 2mM EGS (Thermo Scientific) for 1 hour, followed by 1% of formaldehyde for 15 minutes at room temperature = "
92,GSM3048578,Cell_TGCTAACGCATATGA cell type: hCA3 neuron = 
93,GSM2843592,GM-parallel-1ng-U2_RRBS tissue: GM12878 cell line = 
94,GSM3451079,GM12878 cell 2977 cell type: GM12878 cell line 290-25-Ad1-13-Ad2-61-AAACGGTC-GCTAGAAA_S493; Peak_counts_GM12878_experiment2.txt.gz = 
95,GSM2547209,E11B_hep25_hHep strain: NA; cell type: Single cell transcriptome from adult liver Single cell transcriptome from adult liver; data.human.liver.csv = 
96,GSM2158273,Pancreatic islet cell sample 375 tissue: Pancreatic islets; donor id: Non T2D 8; condition: non-diabetic; age: 60; ethnicity: AI; gender: M; cell subtype: alpha = 
97,GSM3489364,A549-Unreated-Replicate 1-Repeat-Batch2 cell line: A549; treatment: Untreated; 0.05% DMSO; cell type: Epithelial; status: Cancer (adenocarcinoma) BALA009-(DEG)A549TreatmentvsControl.xlsx = 
98,GSM3319881,1004-Regulatory_T-U donor: 1004; cell type: Regulatory_T; lineage: CD4; treatment: no_treament RNA_gene_abundance.txt.gz = 
99,GSM2611243,1T.1 (RRBS) gestational stage: First trimester; tissue: CVS Lim_Processed_data_RRBS.txt = 
100,GSM2890256,RNA-hESC-UTXKD1 cell type: Human Embryonic Stem cell; cell line: H9; genotype/variation: UTX KD = 
101,GSM1949053,"Pt4 RD261 mapki treatment: on-treatment; mapki type: BRAFi+MEKi Patient 4 melanoma, during BRAFi and MEKi treatment, day 261, 1st biopsy; PatientFPKM.xlsx = "
102,GSM3593881,HCT116_EMSY_Rep3 cell line: HCT116 cells; cofactor: EMSY; experimental procedure: STAP-Seq PCR amplified cDNA (STAP-seq transcript); polyA+ RNA; HCT116_EMSY_spikein_normalized.uniq.start.ps.bw; HCT116_EMSY_spikein_normalized.uniq.start.ns.bw; Unique_tagcounts_per_oligo_all_reps.txt; Normalized_tagcounts_per_oligo_merged_reps.txt = 
103,GSM3098739,timeseries sample168 cell type: K562; strain: K562#17 clone with DD-Cas9 stably integrated; sgrna target site: sgRNA chr11; time point: t:18; time series + conditions: T8; conditions: +shield NA = 
104,GSM3485422,iPS-2 [Sample 4] cell type: iPS-derived foreskin fibroblasts; passages: low passage; treatment: untreated DNase-treated; TableS1_PCA_Data.xlsx; TableS1_read_counts.xlsx = 
105,GSM2380526,MGH61_P5_G02 tumor: MGH61 = 
106,GSM2204837,"scler_ht280_H6 cell type: lung epithelial cells; facs purification: live, CD45-, Epcam+, HTII-280+ = "
107,GSM2588113,BJ Old TRACK DM Rep2 cell type: Skin fibroblasts; ectopic gene expression: EMPTY VECTOR; passage from isolation: passage High 45 = 
108,GSM3474209,SU070_Blasts_16 patient id: SU070; patient diagnosis: acute myeloid leukemia; cell type: Blasts = 
109,GSM2109399,JIA patient 29 disease stage: JIA patient with active disease on treatment; tissue: blood; cell type: Peripheral Blood Mononuclear Cells JIA patient = 
110,GSM2695668,siNC biological replication 3 treatment: control siRNA scramble U251-APP cells with control siRNA = 
111,GSM3218752,Keratinocyte cell 346 cell type: Primary epidermal keratinocyte Peak_counts_Keratinocyte_KO.txt.gz; 904-62-Ad1_3-Ad2_17_S65 = 
112,GSM2312392,19Dn1_B11 days in culture: 19; cre line: DCX-; library prep#: 1 = 
113,GSM2173148,44yr_female_cell1269 donor_age: 44; gender: female; inferred_cell_type: alpha Single cell from human pancreas = 
114,GSM869212,THP1-control-1-BWA-SP1 cell line: THP-1; agent: None; sample pair: 1; chip antibody: SP1 = 
115,GSM2740394,"Control23 disease status: C; age at death: 65; Sex: M; neuronal proportion estimate: 0.180095301; chip antibody: H3K27ac (Diagenode, catalog #C15410196, lot# A1723-0041D) = "
116,GSM3065055,DHC152 cell line: PC9; cell type: lung cancer cell line; cell id: PC9_LOW_AF_S36; cell line group: G3_late; batch: 1 sample 166; Targeted DNA; QC: PASSED = 
117,GSM3370649,Organoid8M_R33_C45 tissue: retinal organoid; culture time: 8 month = 
118,GSM3343996,12072017-B11-NA19108 experiment: 12072017; well: B11; individual: NA19108; batch: b5 eset.rds; scqtl-counts.txt.gz; scqtl-annotation.txt; scqtl-annotation-description.txt; quality-single-cells.txt; genes-pass-filter.txt = 
119,GSM2043753,010814 0500-355neg ILC3 individual: 0500-355neg; cell type: Innate Lymphoid Cell 3; hiv status: HIV-; days post hiv-infection: uninfected ILC_matrix_processed.txt = 
120,GSM2491882,Base_Pt8 patient cohort: Familial adenomatous polyposis; tissue: Uninvolved; timepoint: Baseline; treatment: None; patient number: Pt-8 = 
121,GSM2712704,LTBI_1 condition: latent TB infection LTBI subject 1 = 
122,GSM2423174,"ChIP-seq from K562 (ENCLB502JVC) antibody: TRIM25; line: K562; biomaterial_type: immortalized cell line; description: Leukemia, the continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC; biosample encode accession: ENCBS207UAM (SAMN06121701); age: 53 year; dev stage: adult; Sex: female; health state: chronic myelogenous leukemia (CML); lab: Michael Snyder, Stanford; link: ENCBS207UAM at ENCODE; https://www.encodeproject.org/ENCBS207UAM/; link: Derived from ENCODE donor ENCDO000AAD; https://www.encodeproject.org/ENCDO000AAD/; link: ATCC sample source; http://www.atcc.org/Products/All/CCL-243.aspx; link: Growth protocol; https://www.encodeproject.org/documents/bdb989a8-e913-40b6-b1d1-314f27181e9c/@@download/attachment/Snyder_K562%20Cell%20Growth%20Protocol.pdf; link: ENCODE dbxrefs Cellosaurus CVCL_0004; http://web.expasy.org/cellosaurus/CVCL_0004 https://www.encodeproject.org/experiments/ENCSR213VUI/; ***************; biological replicate number: 1; technical replicate number: 1; description: TRIM25 ChIP-seq on human K562; experiment encode accession: ENCSR213VUI; assay title: ChIP-seq; assembly: hg19, GRCh38; possible controls: ENCSR173USI; encode release date: 2016-10-31; lab: Michael Snyder, Stanford; library encode accession: ENCLB502JVC; size range: 450-650 = "
123,GSM1319301,RINGA1 cell line: K562; cell type: erythromyeloblastoid leukemia cells; genotype/variation: expressing RINGA1-GFP fusion protein; chip antibody: Anti-GFP antibody; chip antibody vendor: Abcam; chip antibody cat. #: ab290 chromatin IP (ChIP-seq); C25LHACXX_6_3924 = 
124,GSM3214549,T0_D1.S292 tissue: tumor (PDX MEL006); age: before treatment; genotype: BRAFmut (V600E) SMARTseq2 (Picelli et a. 2014) = 
125,GSM3213700,TNY12_TG1_174T1 malignancy: 1; age: 57; gender: female; group: malignant; barcode: 26.75; barcode.no: 1 3' adapter sequence:TCACTTCGTATGCTGTCCTCTG = 
126,GSM2791161,"4965 disease state: MM; tissue: CD138 depleted bone marrow; date of sample: 2015-01-29; sex (male: 1/ female: 2): 2; age at diagnosis (years): 64; iss stage (1, 2, 3, undetermined (n.d)): 2 = "
127,GSM3382144,"NRGF-HIS/Flt3LG_Cohort 3_day11 mouse strain: NRGF; tissue: blood; human cd45+ purification method: human CD45+ cells enrichment kit (Stem Cell Technologies, Vancouver, British Columbia, Canada); time of extraction post yfv-17d infection: day 11 = "
128,GSM2875052,TBS014-60_S156_L002 tissue source: PBMCs from Mtb exposed patients; cell type: Activated CD8+ T cells; cell subtype: Conventional processed data file:; count_matrix.txt; normalized_count_matrix.txt = 
129,GSM3371383,Organoid8M_R67_C56 tissue: retinal organoid; culture time: 8 month = 
130,GSM3534224,lib4743 [TN02_9063227_23] subject: TN02_9063227; rate of c-peptide change: -0.187161041505324; visit day: 537; age at enrollment: 27.6; Sex: male; race: Other; ethnicity: Not Hispanic or Latino; library batch: Jinfiniti_UPITT; lymphocyte percent: 44.1; neutrophil percent: 39.7 lib4743 = 
131,GSM2992323,G42T2 tissue: Whole blood cells collected from patient after septic shock; patient: G42; timepoint: T1; clinical classification: NR Ribo and Globin depleted library = 
132,GSM2284024,"KhES-1_day5_arm2, rep10 tissue: differentiating embryonic stem cells; differentiation day: day 5; coating matrix: LM411-E8 Single Cell RNA-seq data = "
133,GSM1470406,U-251MG_cytoRNA20 cell line: U-251MG; fraction type: cytoplasmic RNA = 
134,GSM3248914,1001701503_F8 tissue: blood; patient id: 1-020; cell type: B cell; Sex: F; diseaseseverity: dengue fever; numberhumanuniquelymappedreads: 160391; numbervirusreads: 0; age: 24 = 
135,GSM3251951,1001701602_J9 tissue: blood; patient id: 1-026; cell type: NK cell; Sex: F; diseaseseverity: severe dengue; numberhumanuniquelymappedreads: 1572018; numbervirusreads: 0; age: 25 = 
136,GSM2370413,S54_day_7-TB Subjects-140728_I175_FCC4MJ2ACXX_L8_RHUMjlxTAADNRAAPEI-204 tissue: blood; sample_code: S54_day_7; subject: 54; disease state: TB Subjects; treatmentresult: Possible Cure; time: day_7; timetonegativity: Week24; mgit: 18; xpert: 23.3; tgrv: NA = 
137,GSM2172363,21yr_male_cell484 donor_age: 21; gender: male; inferred_cell_type: unsure Single cell from human pancreas = 
138,GSM2304586,Control Inhibitor rep2 cell type: HUVEC; treatment: miR-93-5p inhibitor control S11 = 
139,GSM2576236,4F -ve (Replicate 2) tissue: Heart; cell type: hiPS derived Cardiomycoytes; infection: 4F adenovirus; cell color: negative for FUCCI; replicate number: 2 Cells infected with 4F adenovirus for 48 hours and were negative for FUCCI; 4F -ve 2 = 
140,GSM3339428,08152017-F03-NA18507 experiment: 08152017; well: F03; individual: NA18507; batch: b2 eset.rds; scqtl-counts.txt.gz; scqtl-annotation.txt; scqtl-annotation-description.txt; quality-single-cells.txt; genes-pass-filter.txt = 
141,GSM2616389,1375-B1_TAAGGCGA-CTCTCTAT_L001 subject id: 1375; allergies: Peanut; stimulation: Peanut; tissue/cell type: blood; peripheral blood mononuclear cells (PBMCs); cell subtype: CD154 processed data file:; peanut_gene_raw_counts; peanut_1r1c_RLE_normalized_RPKM = 
142,GSM3231152,DC1_HI24 [ATAC-seq] donor id: DC1; cell type: Monocyte-derived dendritic cells; treatment: HI MTB; time (h): 24 = 
143,GSM3147273,U2D3 cell type: human induced pluripotent stem cell-derived cardiomyocytes; Sex: female; drug: Sunitinib; dose: 10; time: 24; replicate: 3 = 
144,GSM3430890,NFIA-Astro-4 growth condition: N2 media containing LIF/HB-EGF; psc line: H1; prefix: H1_p4 = 
145,GSM1113356,T16_Day0 subject id: T16; time point: Day 0 (pre-vaccine); cell type: circulating B cells processed data file: T16_bcel.txt = 
146,GSM1754830,Untreated MCF7 cells cell line: MCF7; agent: control; rna source: cells Control Cell = 
147,GSM2357108,"HTBE_H1N1_MOI5_12h_1 cell type: Human Tracheobronchial Epithelial Cells; infection: A/California/04/09 (H1N1), MOI 5; time point: 12h; biological replicate: 1 = "
148,GSM3241878,scTrioSeq2Rna_CRC06_PT4_337 cell line: CCL23; disease: Carcinoma single cell RNA seq = 
149,GSM2027259,MCF7.shNT_E2-_rep1 cell line: MCF7; treatment: Control without E2 treatment = 
150,GSM2575334,ColonyH1-WellA3-7dayholiday subclone: H1; condition: 7dayholiday; cell line: WM989 ColonyH1-WellA3-7dayholiday; processed data file: wm9LdB_star_HTSeqCounts_full.tsv = 
151,GSM802410,e1a-infected input control Hiseq_ChIP-seq cell line: IMR90 human primary lung embryo fibroblasts; cell type: contact-inhibited IMR90; infection: e1a-infected; passages: 6 to 10; chip target: none; chip antibody: none input control; e1a-infected input control Hiseq = 
152,GSM3187581,Donor3_P2_Rep3_RNA population: CD71+_CD235- = 
153,GSM1157949,SEQC_ILM_NVS_A_2_L05_ACAGTG_AD0902ACXX seqc sample: A; platform: Illumina HiSeq 2000; site: NVS; library id: 2; lane: L05; barcode: ACAGTG; flowcell: AD0902ACXX = 
154,GSM3663926,MC-98_RNA-Seq [FGC1227_s_7_1_TCCGGAGA-CAGGACGT] cohort: Penn Cohort 2; tissue: liver; individual: MC-98 = 
155,GSM2171930,21yr_male_cell51 donor_age: 21; gender: male; inferred_cell_type: acinar Single cell from human pancreas = 
156,GSM2725473,MUV10-P06-G02 sample type: human tumor = 
157,GSM2092921,TB progressor (040238PAXGENEDAY0_L2.LB15) group: case (TB progressor); bin: 3; age: 13; gender: female; ethnicity: coloured; previous diagnosis of tb: n; tst: 18.2; qft: positive; tissue: blood Processed data: primarySampleJunctions.xlsx - Sheet1 = 
158,GSM3161508,donor309pl1cell019 donor: donor309; donor age: 21.2 years; gender: female; tissue: bone marrow single-cell RNA; 1 out of 192 cells per donor = 
159,GSM3256594,1001702104_I12 tissue: blood; patient id: 1-010; cell type: monocyte; Sex: F; diseaseseverity: severe dengue; numberhumanuniquelymappedreads: 108525; numbervirusreads: 0; age: 17 = 
160,GSM2367162,"six RNA samples of long-lived donors were pooled 10L_S25 age group: long-lived; median age: 92; Sex: 5F_1M; median bmi: 25; pool number: 10L; numbers of participants in the pool: N2_N17_N7_CH_N1_4630 Blood donors were 48 non-obese (BMI<30 kg/m2) Polish Caucasians belonging to either of the two age groups: young (Y, n:24, age range 21-42 years, mean age 28.0±4.0 years) and long-lived (L, n:24, 90-102 years, 94.8±3.9 years). They were free of current infection and of any chronic diseases (type 2 diabetes, cardiovascular disease and its complications, neurodegeneration, cancer, etc.) however, in long-lived group a moderate hypertension and a mild degree physical and cognitive disability were allowed. All participants gave a written informed consent for participation in the study. The study was approved by the Bioethics Committee of the Medical University of Warsaw. ere 48 non-obese (BMI<30 kg/m2) Polish Caucasians belonging to either of the two age groups = "
161,GSM2153940,C1-34-H11_AAGAGGCA-CTAAGCCT_L001_R1_all donor: HSB312; age: NES/P8; c1_chip: C1-34 Zika.GEO.humanBrain.singleCell.gene.RPKM.txt.gz; Zika.GEO.humanBrain.singleCell.gene.count.txt.gz = 
162,GSM2884393,Fibroblasts_4days_rapamycin_rep1 time point: 4days; agent: rapamycin; cell type: fibroblasts; genotype: wild type; source cell line: BJ = 
163,GSM2678698,D2_mRNA_95 cell line: BJ Fibroblasts; treatment: BJ fibroblasts 2 days post induced viral expression of OSKM; tra-1-60: NA D2_FPKM.csv = 
164,GSM2176183,30 Gy cell 27 cell line: Esophageal squamous cell carcinoma line KYSE-180; tissue: Esophagus; irradiation: 30 Gy Corresponds to Normalized_counts.txt column: Sample_Pan_B.C27_mapping.bam = 
165,GSM2380738,MGH61_P8_A07 tumor: MGH61 = 
166,GSM1508030,MN_SCR_KD_Rep1 cell line: H3 ES cells; ectopic expression construct: GFP under 9kb murine Mnx1 promoter; cell treatment: siRNA knockdown by nucleofection + 72 hrs in neural culture media + Retinoic Acid knockdown of control (scramble) = 
167,GSM2423647,"eCLIP from HepG2 (ENCLB094PVE) antibody: HNRNPC; line: HepG2; biomaterial_type: immortalized cell line; biosample encode accession: ENCBS626BOT (SAMN06122193); age: 15 year; dev stage: child; Sex: male; health state: hepatocellular carcinoma; lab: Gene Yeo, UCSD; passage number: 4; link: ENCBS626BOT at ENCODE; https://www.encodeproject.org/ENCBS626BOT/; link: Derived from ENCODE donor ENCDO000AAC; https://www.encodeproject.org/ENCDO000AAC/; link: ATCC sample source; http://www.atcc.org/Products/All/HB-8065.aspx; link: ENCODE dbxrefs Cellosaurus CVCL_0027; http://web.expasy.org/cellosaurus/CVCL_0027 https://www.encodeproject.org/experiments/ENCSR550DVK/; ***************; biological replicate number: 1; technical replicate number: 1; description: eCLIP experiment on HepG2 against HNRNPC; experiment encode accession: ENCSR550DVK; assay title: eCLIP; assembly: GRCh38, hg19; possible controls: ENCSR497ANA; encode release date: 2015-11-09; lab: Gene Yeo, UCSD; library encode accession: ENCLB094PVE; size range: 175-300 = "
168,GSM3343241,11272017-C12-NA18511 experiment: 11272017; well: C12; individual: NA18511; batch: b5 eset.rds; scqtl-counts.txt.gz; scqtl-annotation.txt; scqtl-annotation-description.txt; quality-single-cells.txt; genes-pass-filter.txt = 
169,GSM1852860,Cy67-CD45pos-S2-B6_S18 tumor-of-origin: Cy67; classification (based on inferred cnvs): non-malignant (1); cell types for non-malignant cells: 0 single cell RNA-seq = 
170,GSM1814946,MGH54-P2-F12 cell type: oligodendroglioma single cell = 
171,GSM2747182,HCT116_5.4_1 cell line: HCT116; cell line origin: Human colon carcinoma; aneuploidy: tetrasomy of chromosome 5 normalized to HCT116_1/ HCT116_2/ HCT116_3; processed data file:; HCT116_5.4.txt = 
172,GSM3169935,C27_13_S249 [colonies_scRNA-seq] donor id: donor 1; cell type: primary hematopoietic cells = 
173,GSM2377740,MGH61_P3_C05 tumor: MGH61 = 
174,GSM2245961,GBM cell 2507 diagnosis: glioblastoma; plate id: 1001000241; well: H11; tissue: Tumor; patient id: BT_S4; tsne cluster: 8; cell type: Immune cell; neoplastic: Regular; selection: Oligodendrocytes(GC) Single cell from Tumor; 1001000241.H11 = 
175,GSM1931829,1156 hiPSC-CMs stimulated individual: 1156; tissue: derived cardiomyocytes (CMs) from hiPSC; treatment: with Endothelin stimulation CM harvested 18 hours post stimulation = 
176,GSM2153500,C1-28-C3_AGGCAGAA-TATCCTCT_L002_R1_all donor: HSB312; age: PCW8; c1_chip: C1-28 Zika.GEO.humanBrain.singleCell.gene.RPKM.txt.gz; Zika.GEO.humanBrain.singleCell.gene.count.txt.gz = 
177,GSM2887618,HSSY2 naive 1 cell line: HSSY2 (SS) HSSY2 naive 1 RNA-seq = 
178,GSM2785087,H7CD133SC3 tissue: hepatcellular carcinoma; cell line: HuH-7; cell surface marker: CD133; cell number: 1; cell status: single-cell H7CD133SC3 = 
179,GSM1940685,D37_AS tissue: blood; cell type: CD3+CD4+CD45RA-CCR7+CD25-CCR4+ T cells; disease group: Asthmatic PolyAtail selected messenger RNA; Microscaled (SmartSeq2) cDNA amplification - RNA seq = 
180,GSM2764810,HNSCC16_P11_HNSCC16_P11_C10 enzyme used: SuperScript II; tumor site: Primary (oral cavity) = 
181,GSM2174145,22yr_male_cell2264 donor_age: 22; gender: male; inferred_cell_type: beta Single cell from human pancreas = 
182,GSM1575579,Gene expression_RNA-Seq miR-494 BioRep2 cell line: HeLa; transfected construct: miR-494 processed data file: Gene_expression_miR-494_cuffdiff_fpkm.txt = 
183,GSM3836976,"PBMC1.CC7W2ANXX.SM2_120717p5_B10 Sex: Male; library construction: Smart-seq2 scRNA-seq; full-length; pbmc_hg38_count_matrix.mtx, pbmc_hg38_gene.tsv, pbmc_hg38_cell.tsv = "
184,GSM3254389,1001701802_D18 tissue: blood; patient id: 3-006; cell type: monocyte; Sex: M; diseaseseverity: control; numberhumanuniquelymappedreads: 187995; numbervirusreads: 0; age: 28 = 
185,GSM3633920,VT_S112 treatment: VTP-50469 MCD4899_A224; scRNA-seq VTP-50469-treated #112; SmartSeq2_PDX_VTP50469_Control_featurecount_rawcounts.txt = 
186,GSM2343675,"shRNA RNA-seq from K562 (ENCLB738ZDR) antibody: SMNDC1; line: K562; biomaterial_type: immortalized cell line; description: RNA-seq on K562 cells treated with an shRNA knockdown against SMNDC1.(SMNDC1_BGKLV13_16); biosample encode accession: ENCBS492SXA (SAMN05897249); age: 53 year; lab: Brenton Graveley, UConn; Sex: female; health state: chronic myelogenous leukemia (CML); dev stage: adult; link: ENCBS492SXA at ENCODE; https://www.encodeproject.org/ENCBS492SXA/; link: Derived from ENCODE donor ENCDO000AAD; https://www.encodeproject.org/ENCDO000AAD/; link: General protocol; https://www.encodeproject.org/documents/0897d140-a480-4e81-92d6-a2e1b3081fad/@@download/attachment/SMNDC1_BGKLV13_16.pdf; link: ENCODE dbxrefs Cellosaurus CVCL_0004; http://web.expasy.org/cellosaurus/CVCL_0004 https://www.encodeproject.org/experiments/ENCSR408SDL/; ***************; biological replicate number: 2; technical replicate number: 1; description: shRNA knockdown against SMNDC1 in K562 cells followed by RNA-seq. (SMNDC1 BGKLV13); experiment encode accession: ENCSR408SDL; assay title: shRNA RNA-seq; assembly: GRCh38, hg19; possible controls: ENCSR815CVQ; encode release date: 2014-11-20; lab: Brenton Graveley, UConn; library encode accession: ENCLB738ZDR; size range: >200; spikeins used: NIST profile 15 spike-ins = "
187,GSM1624675,Post-treatment from PDX of sample M029 treatment: post-treatment Vemurafenib; tumor: PDX; material: Fresh Frozen = 
188,GSM3498407,"ChIP-seq from PC-3 (ENCLB406GAH) antibody: EZH2phosphoT487; line: PC-3; biomaterial_type: cell line; description: prostate cancer cell line; biosample encode accession: ENCBS596CTT (SAMN06464454); dev stage: adult; Sex: male; donor_id: ENCDO349AAA; age: 62 year; health state: grade IV, adenocarcinoma; passage number: 3; lab: Bradley Bernstein, Broad; link: ENCBS596CTT at ENCODE; https://www.encodeproject.org/ENCBS596CTT/; link: Derived from ENCODE donor ENCDO349AAA; https://www.encodeproject.org/ENCDO349AAA/; link: ENCODE dbxrefs Cellosaurus CVCL_0035; http://web.expasy.org/cellosaurus/CVCL_0035; link: ATCC sample source; http://www.atcc.org/products/all/CRL-1435.aspx https://www.encodeproject.org/experiments/ENCSR617RSQ/; ***************; biological replicate number: 1; technical replicate number: 1; description:; experiment encode accession: ENCSR617RSQ; assay title: ChIP-seq; assembly: GRCh38, hg19; possible controls: ENCSR328AHC; encode release date: 2018-02-06; lab: Bradley Bernstein, Broad; library encode accession: ENCLB406GAH; size range: 300-600; nucleic acid starting quantity: 22; nucleic acid starting quantity units: ng = "
189,GSM1398110,CCFA_Risk_235 diagnosis: Not IBD; histopathology: NA; deep ulcer: NA; age at diagnosis: 12.833333; gender: Male; paris age at diagnosis: A1b Ileal biopsy in treatment naïve patient with Not IBD Male Control = 
190,GSM3370916,Organoid8M_R46_C32 tissue: retinal organoid; culture time: 8 month = 
191,GSM2764251,HNSCC_17_P9_F02_S62_comb enzyme used: SuperScript II; tumor site: Primary (oral cavity) = 
192,GSM1185948,CGGA_678 history: recurrent anaplastic astrocytomas = 
193,GSM2278381,D16_TRA-1-60-positve_40 cell line: BJ Fibroblasts; treatment: induced viral expression of OSKM; time: 16 days post induced viral expression of OSKM; tra-1-60 status: Positive D16pos_merged.ucsc.bedGraph.gz = 
194,GSM3474950,HSCATAC_P165_79 patient id: SU353; patient diagnosis: acute myeloid leukemia; cell type: pre-leukemic HSCs sample name:; HSCATAC_P165_79 = 
195,GSM2841211,Single-cell_RNA-seq_Subject16_IL7Rlow_TEMRA_Cell034 subject id: Subject16; dengue infections history: DENV negative; cell type: PBMC; cell subtype surface markers: CD3+CD4+CD8α/CD14/CD19-CD45RA+CCR7- CD127-; cell subtype: IL7Rlow_TEMRA Whole Transcriptome Amplification (SmartSeq2 - Picelli et al.2014) = 
196,GSM3290295,D3PrF_BE phenotype: BE; cell subtype: CD326+/CD271+/CD26- Basal Epithelia from normal human prostate tissue = 
197,GSM3145622,"HCC3153_sh1_dox-_H3K27me3_1 [ChIP-seq] cell line: HCC3153; hairpin: shTRPS1-1; treatment: No Dox; chip antibody: H3K27me3; chip antibody info: abcam, cat# ab6002, lot GR275911-2 = "
198,GSM2327826,Ribosome profiling of HCT116 cells upon eIF1 knockdown treated with cycloheximide tissue: colon; cell line: HCT116 ; phenotype: colorectal carcinoma ribosome-associated mRNA = 
199,GSM2644606,input ExoR330fs-2 cell line: T47D ExoR330fs; passages: <5; antibody: N/A processed data files:; input_ExoR330fs.bigWig = 
200,GSM3169954,C28_16_S264 [colonies_scRNA-seq] donor id: donor 1; cell type: primary hematopoietic cells = 
201,GSM2376505,MGH60_P7_H12 tumor: MGH60 OG_processed_data_v2.txt = 
202,GSM1902700,"control monocytes cell type: monocytes; state of health: healthy DNA from 5 experiments was matched; Meth-Seq_Patient_Control_1-550000.xlsx, Meth-Seq_Patient_Control_550001-1155950.xlsx = "
203,GSM2835473,GEO-250 diagnosis: Acute Myeloid Leukemia; tissue: bone marrow or peripheral blood mononuclear cells; gender: male; age (years): 59; response: NA; overall survival (days): 80; life status: dead; predicted ps29mrc group: predicted refractory = 
204,GSM3257712,1001702203_I4 tissue: blood; patient id: 1-036; cell type: unknown; Sex: F; diseaseseverity: severe dengue; numberhumanuniquelymappedreads: 49108; numbervirusreads: 0; age: 32 = 
205,GSM1852200,cy72-CD45-pos-G03-S939-comb tumor-of-origin: cy72; classification (based on inferred cnvs): non-malignant (1); cell types for non-malignant cells: T-cells (1) single cell RNA-seq = 
206,GSM3448787,ULMC215_PLASUNTR_2 condition: Healthy Control; anatomical location: Entire cardiovascular system; rna source: total cell-free biofluid RNA; rna isolation kit: miRNeasy (Qiagen); enzymatic treatment of purified exrna: No (No treatment performed) = 
207,GSM2457297,D125Dp22G08 cell type: cultured embryonic stem cells; cre line: DCX+; days in culture: D125 = 
208,GSM2508531,CML960_diagA5 bcr-abl status: positive; tumor stage: diagnosis; phenotype: Lin-CD34+CD38- CML960 = 
209,GSM2246052,GBM cell 2588 diagnosis: glioblastoma; plate id: 1001000242; well: E2; tissue: Tumor; patient id: BT_S4; tsne cluster: 8; cell type: Immune cell; neoplastic: Regular; selection: Oligodendrocytes(GC) Single cell from Tumor; 1001000242.E2 = 
210,GSM3338091,03072018-F10-NA18522 experiment: 03072018; well: F10; individual: NA18522; batch: b6 eset.rds; scqtl-counts.txt.gz; scqtl-annotation.txt; scqtl-annotation-description.txt; quality-single-cells.txt; genes-pass-filter.txt = 
211,GSM1810764,T75_P3_F10_ILC2 tonsil donor: Donor T75; facs gating: ILC2; cell type: tonsil Innate lymphoid cells = 
212,GSM3272635,BRCA1_WT_Exon2_Rep2_Day11 cell line: cell line: HAP1; library: Day 11 gDNA sample; sample name: X2r2-post amplicon = 
213,GSM3689833,siRNA_SNHG15_rep1 [S1] cell line: LoVo; cell type: Human colorectal cancer cell line; treatment: siRNA_SNHG15 transfected siRNA1_S1 = 
214,GSM2311834,12Dp4_C09 days in culture: 12; cre line: DCX+; library prep#: 4 = 
215,GSM3476192,human white blood cells single cells H3K27me3 Ab+PA-Mnase-28 cell type: white blood cells; antibody-mnase: H3K27me3 Ab + PA-MNase GB401993 = 
216,GSM1956715,I2_plate14_E_7 fsc-a: 118262; fsc-w: 67561; fsc-h: 114718; ssc-a: 59009; ssc-w: 65811; ssc-h: 58762; lin: -60; cd34: 4901; cd10: 1025; cd7: 20; cd45ra: 219; cd90: 2453; cd49f: 427; cd135: 3862; cd38: 956; facs time: 13218 = 
217,GSM2727775,BCH869_PDX-P02-H09 sample type: patient-derived xenogrft (PDX) = 
218,GSM1298108,RNA Pool 10 Lane 1 GD tissue: blood; index: ACCGGC; upper_protocol: SLX-Transcriptome; lower_protocol: Illumina Index; taxonomy_id: 9606; well_location: B04; library: INX745; flowcell: C0HHGACXX; lane: 1; treatment: GD; pool: TRUE; Sex: NA; internal_id: 10; wbc (10e9/l): NA; neu (10e9/l): NA; lym (10e9/l): NA; mono (10e9/l): NA; eos (10e9/l): NA; baso (10e9/l): NA; rbc (10e12/l): NA; plt (10e9/l): NA; rna volume (ul): 45; rna amount (ng): 4735.8; rna concentration (ng/ul): 105.24; nanodrop 260/280: 2.05; nanodrop 260/230: 0.36; rin: 8.3; total reads: 3974798; mapped reads: 242640 = 
219,GSM2627401,Blood_Platelets_NKI-NSCLC-0229-TR2488 disease: NSCLC NKI-NSCLC-0229-TR2488 = 
220,GSM3071824,RRBS Glioblastoma patient pat_224 Surg.1 FFPE [pat_224_N1173_07] idh status: wildtype; center: MedUni Vienna; sample group: Glioblastoma patient; surgery number: 1; multisector: No; sample type: FFPE pat_224_N1173_07 = 
221,GSM1832447,A2_N705_S507 tissue: Cerebral Cortex; developmental stage: GW20.5 polyA RNA; single cell = 
222,GSM2305472,S_0 treatment: Short isoform knockdown; time (hours): 0; cell line: U2OS = 
223,GSM2902455,"lt-NES_201B7_H3K27ac_rep2 tissue: hiPSC-derived lt-NES; genotype/variation: wild type; chip-antibody: H3K27ac (MBL, MABI0309) = "
224,GSM2314691,Brx74_1_SC2_032813 cell type: circulating tumor cells; patient: Brx74; progression: Visceral (+) circulating cells in lysis buffer = 
225,GSM3146937,C1-1772117-118_E06 cell type: long-term self-renewing neuroepithelial-like stem cells = 
226,GSM3191445,R42015-519pf_62-IR_L4 mgs_level: 2; age: 75; Sex: F; rin: 6.7; pmi: 24.22; tissue: retina punch = 
227,GSM2987950,HBL_1_c_REL cell line: HBL_1; cell type: ABC-Like DLBCL cell line; chip antibody: c-REL (C); concentration: 1 in 200; chip antibody manufacturer: Santa Cruz Biotech Immunoprecipitated genomic DNA = 
228,GSM1851150,cy80-Cd45-pos-PD1-pos-S111-E03-S111-comb tumor-of-origin: cy80; classification (based on inferred cnvs): non-malignant (1); cell types for non-malignant cells: T-cells (1) single cell RNA-seq = 
229,GSM2711793,RKO-PRDM1α-OE-rep1 cell line: RKO; cell type: colon epithelial carcinoma PRDM1-alpha overexpressed colon cancer RKO cells = 
230,GSM2616695,FARI_1504_G9 subject id: FARI_1504; allergies: Peanut; stimulation: Peanut; tissue/cell type: blood; peripheral blood mononuclear cells (PBMCs); cell subtype: CD154 processed data file:; peanut_gene_raw_counts; peanut_1r1c_RLE_normalized_RPKM = 
231,GSM2806052,MESA_smoker_E1 cell type: primary circulating CD14+ cells; smoking status: smoker; population: MESA = 
232,GSM2607659,F3_014_V1_T0 tissue: Whole blood; subject id: F3_014; condition: Baseline; test day (visits 1-5: v1-v5): V1; time point (h): 0h = 
233,GSM3123650,226x5h4 tissue: Patient derived xenograft; treatment: vehicle control; disease state: pancreatic cancer; tumor source: 226 226_normalized_counts.txt = 
234,GSM3203386,MGH00478_CD45pos_2_S345 tumor-of-origin: Mel478; treatment-group: treatment.naive; cohort: New; cell type: T.cell Full-length RNAseq (SMART-Seq2) reads.; processed data file: counts.csv; processed data file: tpm.csv; processed data file: cell.annotations.csv = 
235,GSM1851294,cy79-p3-CD45-pos-PD1-pos-AS-C2-R1-F12-S456-comb tumor-of-origin: cy79; classification (based on inferred cnvs): non-malignant (1); cell types for non-malignant cells: T-cells (1) single cell RNA-seq = 
236,GSM3457926,TR4PL23_1O subject id: Aph1; cell type: cd34+ HSPC; tissue: Peripheral blood; method: 3'-TARGET-seq; disease timepoint: baseline; diagnosis: healthy control; donor type: normal; primer mix: IF0137_mix; batch: batch_1; plate: TR4PL23; cd45ra: 1315.08; cd90: 5843.25; cd38: 6525.56; lineage_viability: 7721.96; cd34: 23456.97; cd123: 2467.84; mutation: WT; genes.detected: 2038; input.reads: 29335; unique.mapped: 14848; multimap: 2045; mitochondrial_reads: 488; library.size: 9729; ercc.count: 450; genotype.class: realclone Rodriguez-Meira_et.al_3TARGET_counts.txt = 
237,GSM1251882,HeLa_NO_DSase_minusP_rep1 cell line: HeLa; crosslinker: none; rnase: dsRNase (RNase V1); protein-bound: no Processed data file: HeLa_NO_DSase.CSAR_PPS_FDR05.bed = 
238,GSM3327376,PT089_P3_C07_S319 tissue: breast; breast cancer subtype: TNBC; patient: PT089 = 
239,GSM3339191,08112017-B06-NA19257 experiment: 08112017; well: B06; individual: NA19257; batch: b2 eset.rds; scqtl-counts.txt.gz; scqtl-annotation.txt; scqtl-annotation-description.txt; quality-single-cells.txt; genes-pass-filter.txt = 
240,GSM1574762,PHH3_Compound_1uM IonXpress_021 individual: PHH3; cell type: primary human hepatocytes; treatment: Compound 1uM; rna conc: 50.1; library concentration: 15792.4 IonXpress_021 = 
241,GSM1098359,METSIM6835 age: 52; tissue: adipose tissue; log10 body mass index: 1.533768088; log10 basal metabolic rate (kcal): 2041; log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.507089067; log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.375208909; plasma free fatty acids under the curve ogtt (mmol/l * min): 32.7; fat mass (%): 29; log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.902375114; plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 225; log10 homair (insulin resistance index based on homa): 0.560252115; log10 homais (insulin secretion index based on homa): 2.013161446; log10 insulin area under the curve (ogtt) (pmol/l * min): 4.658736206; insgenin (insulinogenic index): 2.082186756; log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.555433042; log10 matsuda insulin sensitivity index: 0.506696474; muscle mass (%): 41.8; lg10 serum c-reactive protein (mg/l): 0.472756449; lg10 plasma adiponectin (mg/l): 0.602059991; ogtt fasting plasma free fatty acid (mmol/l): 0.33; ogtt 30 min plasma free fatty acid (mmol/l): 0.41; ogtt 120 min plasma free fatty acid (mmol/l): 0.07; ogtt fasting plasma glucose (mmol/l): 6.1; ogtt 30 min plasma glucose (mmol/l): 9.7; ogtt 120 min plasma glucose (mmol/l): 6.3; log10 il1 receptor antagonist (pg/ml): 2.246818521; log10 il1 beta (pg/ml): -1.045757491; log10 ogtt fasting plasma insulin (mu/l): 1.127104798; ogtt 30 min plasma insulin (mu/l): 1.933993164; ogtt 120 min plasma insulin (mu/l): 1.697229343; log10 ogtt fasting plasma proinsulin (pm/l): 1.361727836; ogtt 30 min plasma proinsulin (pm/l): 1.681241237; ogtt 120 min plasma proinsulin (pm/l): 1.847572659; log10 bioimpedance: Resistance: 2.648360011; log10 bioimpedance (reactance): 1.748188027; waist to hip ratio: 1.050420168; log10 serum bilirubin (umol/l): 1.51851394; log10 serum alanine aminotransfrase (u/l): 1.591064607; log10 creatinine (umol/l): 1.913813852; log10 total cholesterol (mmol/l): 0.831869774; log10 ldl cholesterol (mmol/l): 0.663700925; log10 hdl cholesterol (mmol/l): 0.068185862; log10 total triglycerides (mmol/l): 0.359835482; log10 serum apoa1 (g/l): 0.176091259; log10 serum apob (g/l): 0.204119983; log10 urinary albumin excretion rate (ug/min): 1.021189299 = 
242,GSM1965955,"single H9 hESCs differentiated for 12 hours [H9.12h_094] passage: passage 30-35; facs sorting: not sorted H9 cells were differentiated in E8 with BMP4 (5ng/ml), Activin A (25ng/ml) and CHIR99021 (1uM) for the first 2 days, then withdraw CHIR99021 for 2 days. Cells are sampled at the indicated time.; sc_time_course_ec.csv; H9.12h_094 = "
243,GSM2678208,Niro_dcell_2_B09_S117 cell type: BDCA3+ sorted dendritic cell = 
244,GSM3740224,Human fetal liver (G5_163#1191) sample type: Freshly isolated human fetal liver homegenate; sample id: Human fetal liver 1; Sex: Unknown; age: 15 postconceptional weeks (pcw); developmental stage: fetal = 
245,GSM2863017,"P3HR1_10uM_8hr_4 cell type: B lymphocyte; inducible expression system: none; timepoint: 8 hour; cell line: P3HR1; treatment: 10 uM KI-MS2-008 counts_raw_cpms.txt; Merged fastq files contain genomic reads with barcode informations concatenated with read IDs; collapsed reads contain single exemplars of reads, collapsed by UMI and reads sequence, which were used for downstream analyses. = "
246,GSM1817127,Blood_Platelets_Lung-L39 patient id: Lung-L39; cancer type: Lung; batch: Batch06; mutational subclass: KRAS; tissue: blood; cell type: thrombocytes = 
247,GSM3253502,1001701703_M19 tissue: blood; patient id: 3-018; cell type: monocyte; Sex: F; diseaseseverity: control; numberhumanuniquelymappedreads: 212848; numbervirusreads: 0; age: 23 = 
248,GSM1205982,SEQC_NB247 tissue: neuroblastoma; dataset: 1; Sex: M; age at diagnosis: 1267; mycn status: 0; high risk: 1; inss stage: 4; class label: N/A; progression: 1; death from disease: 0 = 
249,GSM634766,Human ES cells replicate 2 - mRNA run 7 strain: HES2 mRNA from human ES cells = 
250,GSM2090582,NC-P-26 disease state: normal = 
251,GSM2074446,CY75_1_CD45_CD8_7__S210_comb disease state: melanoma; tumor index: 75 = 
252,GSM2312047,12Dp1a_A08 days in culture: 12; cre line: DCX+; library prep#: 1 = 
253,GSM3254268,1001701801_O12 tissue: blood; patient id: 3-006; cell type: unknown; Sex: M; diseaseseverity: control; numberhumanuniquelymappedreads: 106; numbervirusreads: 0; age: 28 = 
254,GSM3703919,control 1 cell line: Huh7; cell type: Hepatocellular carcinoma; genotype: sh-control = 
255,GSM2542502,singles-BM0828-CLP-frozen-151103-86 tissue: CD34+ Bone Marrow; cell type: CLP = 
256,GSM3362577,Sample-39: MRucMi_5 tissue: iPSC derived from umbilical cord of EOPE pregnancy; gender: male = 
257,GSM1946457,cell line K36M #1 spike-in input repeat 1 cell line: immortalized juvenile costal chondrocyte cell line T/C 28a2; mutation: K36M; media: DMEM; cell cycle stage: asynchronization; chip antibody: none; spike-in: yeast reference chromatin sample name: hj84 = 
258,GSM3257313,1001702202_H18 tissue: blood; patient id: 1-036; cell type: monocyte; Sex: F; diseaseseverity: severe dengue; numberhumanuniquelymappedreads: 930223; numbervirusreads: 0; age: 32 = 
259,GSM2605564,TTC48-0407 patient: P0407; majorcluster: CD8_Cluster4-LAYN; sampletype: TTC = 
260,GSM3169839,C19_12_S152 [colonies_scRNA-seq] donor id: donor 1; cell type: primary hematopoietic cells = 
261,GSM3346136,S57P4P160125UOXCC12A08.R1.star.bam cell type: iPSC-derived neurons; time point: FP55; site: D; well: A08; batch: 4; cell line: SBAD3 = 
262,GSM1956517,I2_plate11_E_1 fsc-a: 95778; fsc-w: 72002; fsc-h: 87176; ssc-a: 81581; ssc-w: 67911; ssc-h: 78728; lin: 382; cd34: 4583; cd10: 199; cd7: 228; cd45ra: 178; cd90: -177; cd49f: 1884; cd135: 637; cd38: 3969; facs time: 11481 = 
263,GSM2528135,"F57 scan-b external id: Q008239.C008213.S000714.l.r.m3.c.lib.g.k.a.t; instrument model: HiSeq 2000; age at diagnosis: 69; tumor size: 9; lymph node group: NodeNegative; lymph node status: NodeNegative; er status: 1; pgr status: 1; her2 status: 0; ki67 status: NA; nhg: G2; er prediction mgc: 1; pgr prediction mgc: 1; her2 prediction mgc: 0; ki67 prediction mgc: 0; nhg prediction mgc: G2; er prediction sgc: 1; pgr prediction sgc: 1; her2 prediction sgc: 0; ki67 prediction sgc: 0; pam50 subtype: LumB; overall survival days: 2217; overall survival event: 0; endocrine treated: 0; chemo treated: 0 ER/PgR/HER2/Ki67: 0 negative/normal/low, 1 positive/amplified/high; processed data file:; gene_expression_3273_samples_and_136_replicates_transformed.csv; transcript_expression_3273_samples_and_136_replicates.csv = "
264,GSM2323094,IGTB737_activated T cells_RNA-seq tissue: blood; activation: anti-CD3 and anti-CD28; date.of.visit: 8/3/2011; time.of.visit: 8:11 AM; Sex: Male; age: 40; race: Caucasian; ethnicity: Non-Hispanic; height..cm.: 178; weight..kgs.: 94.05; bmi: 29.68375; systolic: 112; diastolic: 74; seq.batch: 2; prep.batch: 5 IGTB737 = 
265,GSM3398469,"H3K36me3 Hypoxia n2 chip antibody: H3K36me3 (61101, Active Motif); treatment: 1H of 1% O2; cell line: HeLa = "
266,GSM1583160,TS110 sample type: Tumor sample; tissue: thyroid; diagnosis: papillary thyroid carcinoma = 
267,GSM3024914,PDX_KPT_H3K27ac tissue: PDX2 patient derived xenograft; cell type: AML; treatment: 100nM Selinexor = 
268,GSM1919394,P08_lcm_tumor diagnosis: colorectal cancer; tissue: Colorectal tumor microvasculature; sample type: Laser-capture microdissected sample; patient: Patient 08; patient treatment status: Treatment-naïve = 
269,GSM2946602,"RNA-Seq Dox Plus, 12hr treatment: Doxycycline Plus; cell line: H9 hESCs with Dox inducible Glis3 expression; time: 12 hr = "
270,GSM3337441,02242018-H08-NA19130 experiment: 02242018; well: H08; individual: NA19130; batch: b6 eset.rds; scqtl-counts.txt.gz; scqtl-annotation.txt; scqtl-annotation-description.txt; quality-single-cells.txt; genes-pass-filter.txt = 
271,GSM2357889,d18_batch2_S4 tissue: hiPSCs-derived kidney organoid (18 days differentiation); clone: human iPSC line CRL1502 (clone C32); batch: batch2; vial: vial4 = 
272,GSM2355552,RRBS_WIBR2_ESC_p15_rep1 cell type: Human embryonic stem cells WIBR2 ESC p15 rep1 = 
273,GSM2514561,DMS-treated-rep1 cell line: HEK293T; treatment: 3.3% DMS; molecule subtype: mRNA 3' end = 
274,GSM2408166,K562_Cryo_Exp_1_044U_MSCB-090 cell type: cell line derived from human leukemia cells; cell line: K562 cryopreserved cells; K562_Cryo_Exp_1.tsv = 
275,GSM3313830,RHH1642 (scRNA-seq) disease state: oral squamous cell carcinoma (OSCC); cell type: Metastatic; passages: 13-15; response to cisplatin: Sensitive Sensitive = 
276,GSM1937457,"SU048-Leuk-Rep1-150212 cell type: acute myeloid leukemia, blast cell; donorid: SU048; sample type: primary human leukemia cell from cryopreserved sample library strategy: ATAC-seq = "
277,GSM1395744,"Single cell mRNA-seq_MGH29_E10 patient id: MGH29; cell type: Glioblastoma Please note that this sample did not pass the quality control filtering (described in the data processing field), thus was excluded from further data processing = "
278,GSM1965240,"single DEC derived from H1 hESC [DEC_Batch2.113] passage: passage 30-35; facs sorting: FACS sorted by CXCR4+ H1 cells were seeded in E8 with BMP4 (5ng/ml), Activin A (25ng/ml) and CHIR99021 (1uM) for the first 2 days, then withdraw CHIR99021 for 3 days.; sc_cell_type_ec.csv; DEC_Batch2.113 = "
279,GSM3320431,24h Veh Replicate 1 timepoint: 24h; celltype: HPAF-II; condition: Veh = 
280,GSM2287005,NPC single cell 19 cell type: iPSC-derived neural progenitor cells; gender: male; sample type: Single Cell = 
281,GSM1965003,single H9 hESC cell [H9_Batch1.032] passage: passage 30-35; facs sorting: not sorted H9 cells were routinely maintained at the undifferentiated state in E8 medium on Matrigel; sc_cell_type_ec.csv; H9_Batch1.032 = 
282,GSM3501873,Tumor Pat12 tissue: gastric cancer; subject id: Pat12; histology: Diffuse; msi: MSS/MSI-L; ebv: Negative = 
283,GSM2395570,Day0_C73 cell type: Human dermal fibroblasts Single Cell RNA-seq data = 
284,GSM2603759,NTH2-75-0508 patient: P0508; majorcluster: CD4_Cluster4-GZMA; sampletype: NTH = 
285,GSM2726151,BCH836-P08-H12 sample type: human tumor = 
286,GSM3103691,"CES_OZ_H3K4me3 Sample 287 disease: CLL; donor: OZ; chip antibody: Rabbit polyclonal H3K4me3 (Abcam, ab8580); treatment: none bigWig = "
287,GSM3444521,"AK178_H3K9me3_ChIP-seq subtype: RTK_II; gender: female; age: 57; survival_status: dead; os (overall survival, month): 8; progression: 1; pfs (progression-free survival, month): 6; chr7_gain: 1; chr10_loss: 1; chr19_gain: 1; chr20_gain: 0; idh1 mutation status: wt; idh2 mutation status: wt; egfr_amplification: 1; pten_deletion: 0; mdm2_amplification: 0; mdm4_amplification: 0; pdgfra_amplification: 0; cdkn2a_b_deletion: 1; cdk4_amplification: 0; met_amplification: 0; molecule subtype: genomic DNA and associated chromatin; chip antibody: H3K9me3; chip antibody vendor: Active Motif; chip antibody cat.#: AM#39161; chip antibody lot #: 3 processed data file:; AK178_ChromHMM_18states.bed; AK178_ChromHMM_simplified_7states.bed; RTK_II_ChromHMM_18states.bed; RTK_II_ChromHMM_simplified_7states.bed = "
288,GSM2272006,1772122317_B11 tissue: ventral midbrain; Sex: ?; age: 6w; inferred cell type: hProgBP EmbryoMoleculeCounts.cef = 
289,GSM3454803,8d_3 cell line: MCF10A; agent: TGF-beta; time: 8 days cell induced by TGF-beta for 8 days = 
290,GSM2142626,L867T tumor (t) or normal (n): L867T; stage tnm: 5; histology: 2; surgery date: 2010-02-23; age: 62; gender: female; vital date: 2011-01-06; dead: 1; smoking: 1; ps who: 0 = 
291,GSM2800812,E2 RNA-Seq cell: Bel-7402 cell; reagent: Erastin (Selleck S7242) gene_expression.txt = 
292,GSM3397418,HMC1.2_AQ1_2uM_3 dev_stage: Adult; cell type: Human-derived mast cell leukemia; passages: 5-30; treatment: 2uM G-quadruplex-biding ligand AQ1 JEG-3-4 = 
293,GSM3124604,58_83_Male_Caucasian cell id: AG04457; disease: Normal; Sex: Male; age: 83; ethnicity: Caucasian fpkm.txt = 
294,GSM3357048,Yellow TGFlo cell type: Primary hepatic stellate cells; stimulation: TGFlo; lot: Yellow; barcode: MPS087820 mRNA; processed data file: raw_data_GEO-20180814.csv; processed data file: norm_data_GEO-20180814.csv = 
295,GSM3161088,donor302pl4cell175 donor: donor302; donor age: 59.2 years; gender: male; tissue: bone marrow single-cell RNA; 1 out of 192 cells per donor = 
296,GSM1966584,single cell H1 hESC cell [H1_Exp1.055] passage: passage 30-35; facs sorting: not sorted GSM1562435; sc_cell_type_ec.csv; H1_Exp1.055 = 
297,GSM3272518,BRCA1_lig4_Exon2_Rep2_Day5_cDNA cell line: HAP1-Lig4KO; library: Day 5 cDNA sample; sample name: X2rL42-rna amplicon = 
298,GSM3604193,HBG1-RNA-3: HBG1 transfection RNA replicate 3 cell line: HEL 92.1.7; cell type: Human erythroblast cancer cell line Targeted barcode amplification incl. UMIs = 
299,GSM3048176,Cell_AGACCCTGGCAGCAA cell type: hCA3 neuron = 
